Page 128 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 128
Liver Transplantation / Surgery: Clinical (Cont.)
P0052 INFUSION OF THIRD-PARTY MESENCHYMAL STROMAL
CELLS AFTER LIVER TRANSPLANTATION: A PHASE I,
OPEN-LABEL, CLINICAL STUDY
Olivier Detry*, Morgan Vandermeulen, Marie-Hélène Delbouille,
Arnaud Deroover, Joan Somja, Noella Bletard, Alexandra Briquet,
Chantal Lechanteur,Yves Beguin, Belgium
P0053 DINSTICT INTRAHEPATIC CYTOKINE PROFILES FOR THE
DIFFERENTIATON OF ACUTE CELLULAR REJECTION
VS RECURRENT HEPATITIS C IN LIVER TRANSPLANTED
PATIENTS
Paraskevi Fytili*, Till Krech, Andrea Gonnermann, Anika Großhennig,
D Jonigk, Frank Lehner, Michael P. Manns, Armin Koch, Jan U. Becker,
Heiner Wedemeyer, Germany
P0054 SAFETY AND EFFICACY OF SUBCUTANEOUS HEPATITIS B
IMMUNOPROPHYLAXIS USING “ON DEMAND” APPROACH
ePOSTERS AND COST ANALYSIS: A SINGLE CENTER EXPERIENCE
Silvia Pecere*, Anna Baldan, Maria Grazia Lucà, Luisa Pasulo,
Annalisa Tortora, Matteo Rota, Stefano Fagiuoli, Italy
P0055 SAFETY AND EFFICACY OF ANTICOAGULATION THERAPY
FOR PORTAL/SPLANHNIC VEIN THROMBOSIS IN PATIENTS
WITH LIVER CIRRHOSIS ON THE WAITING LIST FOR LIVER
TRANSPLANTATION
Liana Gheorghe, Speranta Iacob*, Carmen Ester, Razvan Iacob,
Cristian Gheorghe, Irinel Popescu, Romania
P0056 THE IMPACT OF METABOLIC SYNDROME AND
PREVALENT LIVER DISEASE ON LIVING DONOR LIVER
TRANSPLANTATION: A PRESSING NEED TO EXPAND THE
POOL
Waleed Al-Hamoudi*, Faisal Abaalkhail, Abdurahman Bendahmash,
Naglaa Allam, Nasser Almasri, Hamad Al-bahili, Mohammed Al-Sebayel,
Dieter Broering, Hussien Elsiesy, Saudi Arabia
TOP 10% BACTERIOBILIA IN LIVER TRANSPLANTED PATIENTS
YI P0057 Mario J. Silva*, Julio Veloso, Helena Peres, Teresa Pina, Margarida Pinto,
Victor Duarte, Eduardo Barroso, Portugal
128 The International Liver Congress™ 2015 • ILC Programme
P0052 INFUSION OF THIRD-PARTY MESENCHYMAL STROMAL
CELLS AFTER LIVER TRANSPLANTATION: A PHASE I,
OPEN-LABEL, CLINICAL STUDY
Olivier Detry*, Morgan Vandermeulen, Marie-Hélène Delbouille,
Arnaud Deroover, Joan Somja, Noella Bletard, Alexandra Briquet,
Chantal Lechanteur,Yves Beguin, Belgium
P0053 DINSTICT INTRAHEPATIC CYTOKINE PROFILES FOR THE
DIFFERENTIATON OF ACUTE CELLULAR REJECTION
VS RECURRENT HEPATITIS C IN LIVER TRANSPLANTED
PATIENTS
Paraskevi Fytili*, Till Krech, Andrea Gonnermann, Anika Großhennig,
D Jonigk, Frank Lehner, Michael P. Manns, Armin Koch, Jan U. Becker,
Heiner Wedemeyer, Germany
P0054 SAFETY AND EFFICACY OF SUBCUTANEOUS HEPATITIS B
IMMUNOPROPHYLAXIS USING “ON DEMAND” APPROACH
ePOSTERS AND COST ANALYSIS: A SINGLE CENTER EXPERIENCE
Silvia Pecere*, Anna Baldan, Maria Grazia Lucà, Luisa Pasulo,
Annalisa Tortora, Matteo Rota, Stefano Fagiuoli, Italy
P0055 SAFETY AND EFFICACY OF ANTICOAGULATION THERAPY
FOR PORTAL/SPLANHNIC VEIN THROMBOSIS IN PATIENTS
WITH LIVER CIRRHOSIS ON THE WAITING LIST FOR LIVER
TRANSPLANTATION
Liana Gheorghe, Speranta Iacob*, Carmen Ester, Razvan Iacob,
Cristian Gheorghe, Irinel Popescu, Romania
P0056 THE IMPACT OF METABOLIC SYNDROME AND
PREVALENT LIVER DISEASE ON LIVING DONOR LIVER
TRANSPLANTATION: A PRESSING NEED TO EXPAND THE
POOL
Waleed Al-Hamoudi*, Faisal Abaalkhail, Abdurahman Bendahmash,
Naglaa Allam, Nasser Almasri, Hamad Al-bahili, Mohammed Al-Sebayel,
Dieter Broering, Hussien Elsiesy, Saudi Arabia
TOP 10% BACTERIOBILIA IN LIVER TRANSPLANTED PATIENTS
YI P0057 Mario J. Silva*, Julio Veloso, Helena Peres, Teresa Pina, Margarida Pinto,
Victor Duarte, Eduardo Barroso, Portugal
128 The International Liver Congress™ 2015 • ILC Programme
